Evidence map›Paper›PMID 41909281›Full record

ArticleCureus2026

Impact of BMI on Organs at Risk Dose for Cervical Cancer Treated With Definitive Radiation Therapy Followed by Brachytherapy Boost.

Justin Tang, Caroline Oska, Xianhong Xie, Ilan Small, Keyur J Mehta, Ryung S Kim, Ravindra Yaparpalvi

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Justin TangRadiation Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, USA.
Caroline OskaRadiation Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, USA.
Xianhong XieEpidemiology and Public Health, Albert Einstein College of Medicine, Bronx, USA.
Ilan SmallRadiation Oncology, Albert Einstein College of Medicine, Bronx, USA.
Keyur J MehtaRadiation Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, USA.
Ryung S KimEpidemiology and Public Health, Albert Einstein College of Medicine, Bronx, USA.
Ravindra YaparpalviRadiation Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Higher body mass index (BMI) is identified as a protective factor in intracavitary brachytherapy (BT) for cervical cancer (CC) treated with definitive radiation therapy, particularly for gastrointestinal toxicity. The impact of BMI on organs at risk (OAR) dose remains unknown as hybrid intracavitary-interstitial applicators are used. Methods Patients with CC who received definitive chemoradiation followed by BT boosts from 2023 to 2025 were included. BT doses to OAR of 0.1cm

Indexed as

bmibrachytherapycervixhdr ir-192hybrid applicator

Identifiers

PMID41909281
PMCPMC13032789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.